• A New Horizon for Treating Alopecia Areata

  • Apr 18 2024
  • Length: 47 mins
  • Podcast

A New Horizon for Treating Alopecia Areata

  • Summary

  • In this episode, we chat with Professor Rodney Sinclair, who is a world leader in hair loss and dermatology and director of Sinclair Dermatology.

    Professor Sinclair discusses some of the new treatments for alopecia areata, such as JAK inhibitors and their impact on patients, including cost and accessibility as well as the importance of early diagnosis to improve the chances of hair regrowth.

    Other topics discussed include the role hairdressers and psychologists can play in providing emotional support to patients.

    If this content has raised feelings that concern you, visit the Lifeline website or call 13 11 14.

    Contact Us

    We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.org

    Meet the Team

    Hosts: Naomi Creek, National Coordinator at GHLF Australia and Jo Burch, Registered Psychologist and Alopecia Patient.

    A podcast episode produced by Ben Blanc, Associate Director of Digital Production and Engagement at GHLF.

    Catch up on all our episodes on our website or on your favorite podcast channel.

    From Hair to There: Life with Alopecia is a new podcast series produced by the non-profit Global Healthy Living Foundation, and made possible with support from Pfizer.

    Learn more at ghlf.org.au/fromhairtothere/

    See omnystudio.com/listener for privacy information.

    Show More Show Less

What listeners say about A New Horizon for Treating Alopecia Areata

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.